Back to HomeBeta

ICD-10 Coding for Elevated PSA(R97.20, R97.21)

Complete ICD-10-CM coding and documentation guide for Elevated PSA. Includes clinical validation requirements, documentation requirements, and coding pitfalls.

Also known as:

High PSAIncreased Prostate-Specific AntigenIncreased PSA levels

Related ICD-10 Code Ranges

Complete code families applicable to Elevated PSA

R97.2Primary Range

Abnormal tumor markers

This range includes codes for abnormal findings of tumor markers, specifically for elevated PSA levels.

Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescriptionWhen to UseKey Documentation
R97.20Elevated prostate specific antigen [PSA]Use when PSA is elevated without a history of prostate cancer or post-treatment context.
  • PSA level >4 ng/mL, adjusted for age
  • Exclusion of transient causes such as recent ejaculation or infection
R97.21Rising PSA following treatment for malignant neoplasm of prostateUse for patients with a history of prostate cancer and rising PSA levels post-treatment.
  • PSA doubling time <12 months post-treatment
  • Correlation with imaging studies

Clinical Decision Support

Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.

Key Information: ICD-10 code for elevated PSA

Essential facts and insights about Elevated PSA

The ICD-10 code for elevated PSA is R97.20, applicable when PSA levels are high without a history of prostate cancer.

Primary ICD-10-CM Codes for elevated psa

Elevated prostate specific antigen [PSA]
Billable Code

Decision Criteria

clinical Criteria

  • PSA level >4 ng/mL without known cause

documentation Criteria

  • Document specific PSA value and rule out transient causes

Applicable To

  • PSA level above age-adjusted normal without known cause

Excludes

  • R97.21 (Rising PSA following treatment for malignant neoplasm of prostate)

Clinical Validation Requirements

  • PSA level >4 ng/mL, adjusted for age
  • Exclusion of transient causes such as recent ejaculation or infection

Code-Specific Risks

  • Misuse for patients with prostate cancer history
  • Incorrect use for screening purposes

Coding Notes

  • Ensure documentation specifies PSA levels and excludes transient causes.

Ancillary Codes

Additional codes that should be used in conjunction with the main diagnosis codes when applicable.

Benign prostatic hyperplasia with lower urinary tract symptoms

N40.1
Use alongside R97.20 if BPH is confirmed.

Differential Codes

Alternative codes to consider when ruling out similar conditions to the primary diagnosis.

Rising PSA following treatment for malignant neoplasm of prostate

R97.21
Use R97.21 for patients with a history of prostate cancer and rising PSA post-treatment.

Elevated prostate specific antigen [PSA]

R97.20
Use R97.20 for elevated PSA without cancer history.

Documentation & Coding Risks

Avoid these common documentation and coding issues when documenting Elevated PSA to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code R97.20.

Impact

Clinical: Leads to unclear clinical picture., Regulatory: May result in audit flags., Financial: Potential claim denials due to lack of specificity.

Mitigation Strategy

Always document exact PSA values., Include clinical context and history.

Impact

Reimbursement: Incorrect coding can lead to claim denials., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate data representation of patient conditions.

Mitigation Strategy

Use R97.20 for diagnostic tests when symptoms are present.

Impact

Reimbursement: Potential for incorrect DRG assignment., Compliance: Violation of coding specificity., Data Quality: Misrepresentation of patient cancer history.

Mitigation Strategy

Use R97.21 for rising PSA in patients with prostate cancer history.

Impact

Using screening codes for symptomatic patients.

Mitigation Strategy

Educate providers on proper code selection based on symptoms and history.

Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.

Frequently Asked Questions

Common questions about ICD-10 coding for Elevated PSA, with expert answers to help guide accurate code selection and documentation.

Documentation Templates for Elevated PSA

Use these documentation templates to ensure complete and accurate documentation for Elevated PSA. These templates include all required elements for proper coding and billing.

Elevated PSA in Primary Care

Specialty: Primary Care

Required Elements

  • PSA level and reference range
  • Exclusion of transient causes
  • Clinical symptoms and history

Example Documentation

Subjective: 58M c/o urinary frequency. No dysuria. PSA 5.8 ng/mL (ref: <4.0). DRE: Prostate 40g, no nodules. Assessment: Elevated PSA (R97.20). Plan: Repeat PSA in 6w.

Examples: Poor vs. Good Documentation

Poor Documentation Example
PSA high; follow up.
Good Documentation Example
PSA elevated to 6.9 ng/mL (prior 4.1 ng/mL 1y ago); PSA velocity +2.8 ng/mL/year; MRI scheduled.
Explanation
The good example provides specific PSA values, historical comparison, and planned follow-up, enhancing clinical clarity.

Need help with ICD-10 coding for Elevated PSA? Ask your questions below.

Ask about any ICD-10 CM code, or paste a medical note

We build tools for
clinician happiness.

Learn More at Freed.ai
Back to HomeBeta

Built by Freed

Try Freed for free for 7 days.

Learn more